PharmaResources (Shanghai) Co., Ltd () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

PharmaResources (Shanghai) Co., Ltd

Why is PharmaResources (Shanghai) Co., Ltd ?

The company declared positive results in Mar'25 after flat results in Dec'24

OPERATING CASH FLOW(Y) Highest at CNY 71.52 MM
PRE-TAX PROFIT(Q) At CNY 9.29 MM has Grown at 1,301%
NET PROFIT(Q) At CNY 10.2 MM has Grown at 312.6%

With ROE of 1.68%, it has a fair valuation with a 2.50 Price to Book Value

Over the past year, while the stock has generated a return of 27.68%, its profits have risen by 48.6%
At the current price, the company has a high dividend yield of 0.4

Market Beating Performance

The stock has generated a return of 27.68% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to PharmaResources (Shanghai) Co., Ltd should be less than 10%
Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PharmaResources (Shanghai) Co., Ltd for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

PharmaResources (Shanghai) Co., Ltd

9.75%

0.67

61.09%

China Shanghai Composite

14.9%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

16.76%

EBIT Growth (5y)

-46.61%

EBIT to Interest (avg)

10.31

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

0.47

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

348.46%

Pledged Shares

Institutional Holding

ROCE (avg)

5.27%

ROE (avg)

3.33%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

149

Industry P/E

Price to Book Value

2.50

EV to EBIT

293.76

EV to EBITDA

24.04

EV to Capital Employed

3.08

EV to Sales

3.75

PEG Ratio

Dividend Yield

0.39%

ROCE (Latest)

1.05%

ROE (Latest)

1.68%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 71.52 MM

PRE-TAX PROFIT(Q)

At CNY 9.29 MM has Grown at 1,301%

NET PROFIT(Q)

At CNY 10.2 MM has Grown at 312.6%

RAW MATERIAL COST(Y)

Fallen by -76.65% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 7.29%

NET SALES(Q)

Highest at CNY 168.69 MM

-9What is not working for the Company

INTEREST(9M)

At CNY 6.7 MM has Grown at 14.74%

DEBT-EQUITY RATIO (HY)

Highest at -14.23 %

INTEREST COVERAGE RATIO(Q)

Lowest at 417.71

OPERATING PROFIT(Q)

Lowest at CNY 9.07 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 5.38 %

Here's what is working for PharmaResources (Shanghai) Co., Ltd

Pre-Tax Profit

At CNY 9.29 MM has Grown at 1,301%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 10.2 MM has Grown at 312.6%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 71.52 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 168.69 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 168.69 MM has Grown at 29.56%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Inventory Turnover Ratio

Highest at 7.29%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -76.65% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for PharmaResources (Shanghai) Co., Ltd

Interest

At CNY 6.7 MM has Grown at 14.74%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 417.71

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at -14.23 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit

Lowest at CNY 9.07 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 5.38 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales